Risk assessment recommendations for diabetic peripheral neuropathy (DPN) have been established by the American Diabetes Association (ADA). The elements of a comprehensive foot examination are described.
Screening standards for diabetic peripheral vascular disease have been established by the American Diabetes Association. A comprehensive table provides specific criteria for screening and diagnosis.
Targets for lipids, blood pressure, and blood glucose to minimize cardiovascular risk have been established by the American Diabetes Association (ADA).
Screening test recommendations for type 2 diabetes have been established by the American Diabetes Association. Comprehensive table provides specific criteria for screening and diagnosis.
An overview of different types of commercially available qualitative and quantitative test instruments for diabetic peripheral neuropathy (DPN) is provided.
Some patients are at increased risk for peripheral vascular disease. The American Diabetes Association (ADA) screening candidacy criteria based on the ankle-brachial index (ABI) are provided.